Fejzo M - Search Results

1

Milstein M, Mooser CK, Hu H, Fejzo M, Slamon D, Goodglick L, Dry S, Colicelli J. Milstein M, et al. Among authors: fejzo m. Cancer Res. 2007 Dec 15;67(24):11510-6. doi: 10.1158/0008-5472.CAN-07-1147. Cancer Res. 2007. PMID: 18089779 Free PMC article.

2

Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.

Fejzo MS, Dering J, Ginther C, Anderson L, Ramos L, Walsh C, Karlan B, Slamon DJ. Fejzo MS, et al. Genes Chromosomes Cancer. 2008 Oct;47(10):873-83. doi: 10.1002/gcc.20592. Genes Chromosomes Cancer. 2008. PMID: 18615678

3

Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.

Wainberg ZA, Anghel A, Desai AJ, Ayala R, Luo T, Safran B, Fejzo MS, Hecht JR, Slamon DJ, Finn RS. Wainberg ZA, et al. Clin Cancer Res. 2010 Mar 1;16(5):1509-19. doi: 10.1158/1078-0432.CCR-09-1112. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179222

4

Periostin promotes ovarian cancer angiogenesis and metastasis.

Zhu M, Fejzo MS, Anderson L, Dering J, Ginther C, Ramos L, Gasson JC, Karlan BY, Slamon DJ. Zhu M, et al. Among authors: fejzo ms. Gynecol Oncol. 2010 Nov;119(2):337-44. doi: 10.1016/j.ygyno.2010.07.008. Epub 2010 Aug 4. Gynecol Oncol. 2010. PMID: 20688362

5

Tissue microarrays from frozen tissues-OCT technique.

Fejzo MS, Slamon DJ. Fejzo MS, et al. Methods Mol Biol. 2010;664:73-80. doi: 10.1007/978-1-60761-806-5_8. Methods Mol Biol. 2010. PMID: 20690054

6

Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK.

Fejzo MS, Ginther C, Dering J, Anderson L, Venkatesan N, Konecny G, Karlan B, Slamon DJ. Fejzo MS, et al. Genes Chromosomes Cancer. 2011 Jun;50(6):434-41. doi: 10.1002/gcc.20868. Epub 2011 Mar 22. Genes Chromosomes Cancer. 2011. PMID: 21432940

7

Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.

Fejzo MS, Anderson L, von Euw EM, Kalous O, Avliyakulov NK, Haykinson MJ, Konecny GE, Finn RS, Slamon DJ. Fejzo MS, et al. Int J Mol Sci. 2013 Feb 1;14(2):3094-109. doi: 10.3390/ijms14023094. Int J Mol Sci. 2013. PMID: 23377018 Free PMC article.

8

POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.

Karlan BY, Dering J, Walsh C, Orsulic S, Lester J, Anderson LA, Ginther CL, Fejzo M, Slamon D. Karlan BY, et al. Among authors: fejzo m. Gynecol Oncol. 2014 Feb;132(2):334-42. doi: 10.1016/j.ygyno.2013.12.021. Epub 2013 Dec 22. Gynecol Oncol. 2014. PMID: 24368280

9

KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition.

Hamidi H, Lu M, Chau K, Anderson L, Fejzo M, Ginther C, Linnartz R, Zubel A, Slamon DJ, Finn RS. Hamidi H, et al. Among authors: fejzo m. Br J Cancer. 2014 Oct 28;111(9):1788-801. doi: 10.1038/bjc.2014.475. Epub 2014 Aug 28. Br J Cancer. 2014. PMID: 25167228 Free PMC article.

10

ADRM1-amplified metastasis gene in gastric cancer.

Fejzo MS, Anderson L, Chen HW, Anghel A, Zhuo J, Anchoori R, Roden R, Slamon DJ. Fejzo MS, et al. Genes Chromosomes Cancer. 2015 Aug;54(8):506-515. doi: 10.1002/gcc.22262. Epub 2015 Jun 6. Genes Chromosomes Cancer. 2015. PMID: 26052681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters